Citigroup
HALO icon

Citigroup’s Halozyme HALO Stock Holding History

Citigroup’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
30,000
+6,300
+27% +$430K ﹤0.01% 2811
2026
Q1 		$1.53M Buy
+23,700
New +$1.67M ﹤0.01% 2840
2025
Q1 		– Sell
-24,000
Closed -$1.15M – 5735
2024
Q4 		$1.15M Buy
+24,000
New +$1.23M ﹤0.01% 3257
2021
Q1 		– Sell
-1,800
Closed -$77K – 6725
2020
Q4 		$77K Sell
1,800
-8,300
-82% -$298K ﹤0.01% 5743
2020
Q3 		$265K Sell
10,100
-26,700
-73% -$744K ﹤0.01% 4395
2020
Q2 		$987K Sell
36,800
-5,400
-13% -$122K ﹤0.01% 3582
2020
Q1 		$759K Sell
42,200
-19,000
-31% -$361K ﹤0.01% 3458
2019
Q4 		$1.08M Buy
61,200
+5,000
+9% +$86.6K ﹤0.01% 3661
2019
Q3 		$872K Sell
56,200
-8,200
-13% -$135K ﹤0.01% 3794
2019
Q2 		$1.11M Buy
64,400
+36,800
+133% +$594K ﹤0.01% 3497
2019
Q1 		$444K Buy
27,600
+6,400
+30% +$104K ﹤0.01% 4312
2018
Q4 		$310K Sell
21,200
-1,800
-8% -$28.7K ﹤0.01% 4590
2018
Q3 		$418K Buy
23,000
+15,500
+207% +$272K ﹤0.01% 4498
2018
Q2 		$127K Sell
7,500
-11,900
-61% -$225K ﹤0.01% 5496
2018
Q1 		$380K Sell
19,400
-14,300
-42% -$277K ﹤0.01% 4274
2017
Q4 		$683K Sell
33,700
-31,600
-48% -$581K ﹤0.01% 3761
2017
Q3 		$1.13M Buy
65,300
+49,400
+311% +$669K ﹤0.01% 3239
2017
Q2 		$204K Sell
15,900
-6,800
-30% -$90.8K ﹤0.01% 4774
2017
Q1 		$294K Sell
22,700
-1,000
-4% -$12.6K ﹤0.01% 4326
2016
Q4 		$234K Sell
23,700
-7,100
-23% -$77.8K ﹤0.01% 5149
2016
Q3 		$372K Sell
30,800
-14,100
-31% -$144K ﹤0.01% 4160
2016
Q2 		$387K Buy
44,900
+3,900
+10% +$38.5K ﹤0.01% 3907
2016
Q1 		$388K Sell
41,000
-500
-1% -$4.71K ﹤0.01% 4410
2015
Q4 		$719K Buy
41,500
+15,400
+59% +$245K ﹤0.01% 3486
2015
Q3 		$351K Buy
26,100
+900
+4% +$18.1K ﹤0.01% 4065
2015
Q2 		$569K Buy
+25,200
New +$443K ﹤0.01% 3588

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Citigroup's HALO Position: Q2 2026 in Review

Citigroup increased its Halozyme (HALO) stake by 177% in Q2 2026, buying an estimated $14.6M and bringing the position to 333,777 shares worth $26.1M. The position accounts for 0.01% of the portfolio, ranked #1022.

Citigroup first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.3M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Citigroup held 333,777 shares of Halozyme worth $26.1M as of Q2 2026.
  • Citigroup bought 213,436 Halozyme shares in Q2 2026, an estimated $14.6M.
  • Halozyme made up 0.01% of Citigroup's portfolio in Q2 2026, its #1022 holding.
  • Citigroup first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Halozyme position peaked at $40.3M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.